Presentation TCT 2024 TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR) Presenter: Allan Schwartz October 30, 2024
Presentation TCT 2024 Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED) Presenter: Mark Dweck October 30, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial Presenter: Philippe Genereux October 28, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial Presenter: Philippe Genereux October 28, 2024
Presentation TCT 2024 TCT 92: Early Transcatheter or Surgical Aortic Valve Replacement Versus Conservative Management in Asymptomatic Patients With Severe Aortic Stenosis: A Systematic Review and Meta-analysis Presenter: Avinash Nankani October 27, 2024
Presentation NY Valves 2024 Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials Presenter: Nicolas M. Van Mieghem June 06, 2024